Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Mirum Pharmaceuticals Raises FY2025 Sales Guidance from $490.000M-$510.000M to $500.000M-$510.000M vs $505.800M Est

Author: Benzinga Newsdesk | November 04, 2025 04:03pm
Mirum Pharmaceuticals (NASDAQ:MIRM) raises FY2025 sales outlook from $490.000 million-$510.000 million to $500.000 million-$510.000 million vs $505.800 million estimate.

Posted In: MIRM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist